Phosphodiesterase 4D is required for β2 adrenoceptor subtype-specific signaling in cardiac myocytes

Proceedings of the National Academy of Sciences of the United States of America

Volumn 102, Issue 3, 2005, Pages 909-914

  Xiang, Yang ^a   Naro, Fabio ^a,b   Zoudilova, Maria ^a   Jin, S L Catherine ^a   Conti, Marco ^a   Kobilka, Brian ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Camp; Heart; Knockout

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; PHOSPHODIESTERASE 4D; PHOSPHODIESTERASE IV; PHOSPHODIESTERASE IV INHIBITOR; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ADRENERGIC SYSTEM; ANIMAL CELL; ARTICLE; CARDIOVASCULAR FUNCTION; HEART CONTRACTION; HEART MUSCLE CELL; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; CYCLIC AMP; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; MICE; MYOCYTES, CARDIAC; ORGAN SPECIFICITY; RECEPTORS, ADRENERGIC, BETA-2; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 14144251238     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0405263102     Document Type: Article

References (35)

1. Lohse, M. J., Engelhardt, S. & Eschenhagen, T. (2003) Circ. Res. 93, 896-906.
2. Devic, E., Xiang, Y., Gould, D. & Kobilka, B. (2001) Mol. Pharmacol. 60, 577-583.
3. Green, S. A., Holt, B. D. & Liggett, S. B. (1992) Mol. Pharmacol. 41, 889-893.
4. Ostrom, R. S., Gregorian, C., Drenan, R. M., Xiang, Y., Regan, J. W. & Insel, P. A. (2001) J. Biol. Chem. 276, 42063-42069.
5. Xiang, Y., Rybin, V. O., Steinberg, S. F. & Kobilka, B. (2002) J. Biol. Chem. 277, 34280-34286.
6. Rybin, V. O., Xu, X., Lisanti, M. P. & Steinberg, S. F. (2000) J. Biol. Chem. 275, 41447-41457.
7. Verde, I., Vandecasteele, G., Lezoualc'h, F. & Fischmeister, R. (1999) Br. J. Pharmacol. 127, 65-74.
8. Conti, M., Nemoz, G., Sette, C. & Vicini, E. (1995) Endocr. Rev. 16, 370-389.
9. Steinberg, S. F. & Brunton, L. L. (2001) Annu. Rev. Pharmacol. Toxicol. 41, 751-773,
10. Jurevicius, J. & Fischmeister, R. (1996) Proc. Natl. Acad. Sci. USA 93, 295-299.
11. Dodge, K. L., Khouangsathiene, S., Kapiloff, M. S., Mouton, R., Hill, E. V., Houslay, M. D., Langeberg, L. K. & Scott, J. D. (2001) EMBO J. 20, 1921-1930.
12. Verde, I., Pahlke, G., Salanova, M., Zhang, G., Wang, S., Coletti, D., Onuffer, J., Jin, S. L. & Conti, M. (2001) J. Biol. Chem. 276, 11189-11198.
13. Perry, S. J., Baillie, G. S., Kohout, T. A., McPhee, I., Magiera, M. M., Ang, K. L., Miller, W. E., McLean, A. J., Conti, M., Houslay, M. D. & Lefkowitz, R. J. (2002) Science 298, 834-836.
14. Baillie, G. S., Sood, A., McPhee, I., Gall, I., Perry, S. J., Lefkowitz, R. J. & Houslay, M. D. (2003) Proc. Natl. Acad. Sci. USA 100, 940-945.
15. Zaccolo, M. & Pozzan, T. (2002) Science 295, 1711-1715.
16. Jin, S. L., Richard, F. J., Kuo, W. P., D'Ercole, A. J. & Conti, M. (1999) Proc. Natl. Acad. Sci. USA 96, 11998-12003.
17. Jin, S. L. & Conti, M. (2002) Proc. Natl. Acad. Sci. USA 99, 7628-7633.
18. Sette, C. & Conti, M. (1996) J. Biol. Chem. 271, 16526-16534.
19. Alvarez, R., Sette, C., Yang, D., Eglen, R. M., Wilhelm, R., Shelton, E. R. & Conti, M. (1995) Mol. Pharmacol. 48, 616-622.
20. Thompson, W. J. & Appleman, M. M. (1971) Biochemistry 10, 311-316.
21. Brunton, L. L. (2003) Sci. STKE 2003, PE44.
22. Cong, M., Perry, S. J., Lin, F. T., Fraser, I. D., Hu, L. A., Chen, W., Pitcher, J. A., Scott, J. D. & Lefkowitz, R. J. (2001) J. Biol. Chem. 276, 15192-15199.
23. Fraser, I. D., Cong, M., Kim, J., Rollins, E. N., Daaka, Y., Lefkowitz, R. J. & Scott, J. D. (2000) Curr. Biol. 10, 409-412.
24. Ludwig, A., Zong, X., Jeglitsch, M., Hofmann, F. & Biel, M. (1998) Nature 393, 587-591.
25. Davare, M. A., Avdonin, V., Hall, D. D., Peden, E. M., Burette, A., Weinberg, R. J., Horne, M. C., Hoshi, T. & Hell, J. W. (2001) Science 293, 98-101.
26. Shiina, T., Kawasaki, A., Nagao, T. & Kurose, H. (2000) J. Biol. Chem. 275, 29082-29090.
27. Rich, T. C., Fagan, K. A., Nakata, H., Schaack, J., Cooper, D. M. & Karpen, J. W. (2000) J. Gen. Physiol. 116, 147-161.
28. Rich, T. C., Fagan, K. A., Tse, T. E., Schaack, J., Cooper, D. M. & Karpen, J. W. (2001) Proc. Natl. Acad. Sci. USA 98, 13049-13054.
29. Weishaar, R. E., Kobylarz-Singer, D. C. & Kaplan, H. R. (1987) J. Mol. Cell. Cardiol. 19, 1025-1036.
30. Movsesian, M. A., Smith, C. J., Krall, J., Bristow, M. R. & Manganiello, V. C. (1991) J. Clin. Invest. 88, 15-19.
31. Kauffman, R. F., Crowe, V. G., Utterback, B. G. & Robertson, D. W. (1986) Mol. Pharmacol. 30, 609-616.
32. Stoclet, J. C., Keravis, T., Komas, N. & Lugnier, C. (1995) Exp. Opin. Invest. Drugs 4, 1081-1199.
33. Kostic, M. M., Erdogan, S., Rena, G., Borchert, G., Hoch, B., Bartel, S., Scotland, G., Huston, E., Houslay, M. D. & Krause, E. G. (1997) J. Mol. Cell. Cardiol. 29, 3135-3146.
34. Kapiloff, M. S. (2002) Mol. Pharmacol. 62, 193-199.
35. Conti, M., Richter, W., Mehats, C., Livera, G., Park, J. Y. & Jin, C. (2003) J. Biol. Chem. 278, 5493-5496.